Summary: Creative Biolabs provides GLP-compliant in vivo test services for anti-WT1 CAR-T cell therapy in acute myelocytic and lymphocytic leukemia, lung cancer, breast cancer and ovarian cancer. Wilms’ tumor 1 (WT1) encodes a transcription factor consisted with four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus, which physiologically plays an essential role in the cell growth and differentiation, especially in the normal development of the urogenital system.
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
